X4 Pharmaceuticals
XFOR
XFOR
60 hedge funds and large institutions have $139M invested in X4 Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% more funds holding
Funds holding: 53 → 60 (+7)
0.95% more ownership
Funds ownership: 2.14% → 3.09% (+0.95%)
Holders
60
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$15.4M | |
| 2 | +$6.93M | |
| 3 | +$6.85M | |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$4.95M |
| 5 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$4.06M |
Top Sellers
| 1 | -$1.15M | |
| 2 | -$451K | |
| 3 | -$430K | |
| 4 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
-$347K |
| 5 |
CAM
ClariVest Asset Management
San Diego,
California
|
-$289K |